Ensar Halilovic
Impact in
- Oncology top 2%
- Cancer-related Molecular Pathways
- Molecular Biology top 5%
- Melanoma and MAPK Pathways
- PI3K/AKT/mTOR signaling in cancer
- Ubiquitin and proteasome pathways
Papers in
- Oncology 18
- Cancer-related Molecular Pathways 11
- Cytokine Signaling Pathways and Interactions 3
-
- Melanoma and MAPK Pathways 8
- Protein Kinase Regulation and GTPase Signaling 3
- Co-authors
- David B. Solit (5 shared papers)Neal Rosen (5 shared papers)Christine A. Pratilas (4 shared papers)Qing‐Bai She (2 shared papers)Madhavi Tadi (2 shared papers)Eric W. Joseph (2 shared papers)Poulikos I. Poulikakos (2 shared papers)Stephen Doxsey (3 shared papers)
- Journals
- Cancer Research (10 papers)European Journal of Cancer (3 papers)Blood (2 papers)Cancer Cell (2 papers)Journal of Clinical Oncology (1 paper)
- Partner nations
- United StatesSwitzerlandFrance
In The Last Decade
Ensar Halilovic
32 papers receiving 2.3k citations
Ensar Halilovic's Hit Papers
Peers
Comparison fields: 5 of 85
- Oncology 862
- Molecular Biology 1.6k
- Cell Biology 359
- Pathology and Forensic Medicine 296
- Cancer Research 226
Countries citing papers authored by Ensar Halilovic
This map shows the geographic impact of Ensar Halilovic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ensar Halilovic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ensar Halilovic more than expected).
Fields of papers citing papers by Ensar Halilovic
This network shows the impact of papers produced by Ensar Halilovic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ensar Halilovic. The network helps show where Ensar Halilovic may publish in the future.
Co-authors
The 25 scholars most cited alongside Ensar Halilovic, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Relief of Profound Feedback Inhibition of Mitogenic Signaling by RAF Inhibitors Attenuates Their Activity in BRAFV600E Melanomas Hit paper breakdown → | 2012 | 415 |
| 2 | 2010 | 350 | |
| 3 | 2010 | 327 | |
| 4 | 2003 | 213 | |
| 5 | 2008 | 195 | |
| 6 | 2010 | 134 | |
| 7 | 2019 | 91 | |
| 8 | 2004 | 80 | |
| 9 | 2008 | 64 | |
| 10 | 2020 | 51 | |
| 11 | 2016 | 51 | |
| 12 | 2021 | 45 | |
| 13 | 2021 | 45 | |
| 14 | 2019 | 44 | |
| 15 | 2017 | 34 | |
| 16 | 2021 | 26 | |
| 17 | 2016 | 25 | |
| 18 | 2016 | 24 | |
| 19 | 2020 | 22 | |
| 20 | 2016 | 15 |
About Ensar Halilovic
Ensar Halilovic is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research and Genetics, having authored 33 papers that have together received 2.3k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (11 papers), Melanoma and MAPK Pathways (8 papers), Advanced Breast Cancer Therapies (5 papers), Cancer Genomics and Diagnostics (4 papers), Computational Drug Discovery Methods (4 papers), Protein Kinase Regulation and GTPase Signaling (3 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Cytokine Signaling Pathways and Interactions (3 papers). The work is most often cited by research in Oncology (862 citations), Molecular Biology (1.6k citations), Cell Biology (359 citations), Pathology and Forensic Medicine (296 citations) and Cancer Research (226 citations). Ensar Halilovic has collaborated with scholars based in United States, Switzerland and France. Frequent co-authors include David B. Solit, Neal Rosen, Christine A. Pratilas, Qing‐Bai She, Madhavi Tadi, Eric W. Joseph, Poulikos I. Poulikakos, Stephen Doxsey, Zhen Wei and Takehiko Sasazuki. Their work appears in journals such as Cancer Research, European Journal of Cancer, Blood, Cancer Cell and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.